Back
Aptevo Therapeutics Vs. Ocular Therapeutix Industry Stock Comparison
Sell
1
APVO
Aptevo Therapeutics
Last Price:
0.18
Seasonality Move:
33.46%
Buy
58
OCUL
Ocular Therapeutix
Last Price:
8.98
Seasonality Move:
1.23%
Sell
1
Aptevo Therapeutics (APVO)
is a Sell
Is Aptevo Therapeutics a Buy, Sell or Hold?
- The current Aptevo Therapeutics [APVO] share price is $0.17. The Score for APVO is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- APVO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
58
Ocular Therapeutix (OCUL)
is a Buy
Is Ocular Therapeutix a Buy, Sell or Hold?
- The current Ocular Therapeutix [OCUL] share price is $8.99. The Score for OCUL is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- OCUL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APVO Stock Price Chart
What is Aptevo Therapeutics's stock price today?
-
The Aptevo Therapeutics share price today is $0.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APVO is experiencing selling pressure, which indicates risk of future bearish movement.
OCUL Stock Price Chart
What is Ocular Therapeutix's stock price today?
-
The Ocular Therapeutix share price today is $8.99
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OCUL is experiencing slight selling pressure.
APVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 23.2 | Sell |
Chaikin Money Flow: | -817579 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.27 - 0.41) | Sell |
Bollinger Bands (100): | (0.29 - 0.77) | Sell |
OCUL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.18 | Buy |
Relative Strength Index (14 RSI): | 58.44 | Buy |
Chaikin Money Flow: | -68150 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.45 - 9.05) | Buy |
Bollinger Bands (100): | (5.85 - 8.53) | Buy |
APVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.27 | Sell |
20-day SMA: | 0.32 | Sell |
50-day SMA: | 0.37 | Sell |
200-day SMA: | 3.12 | Sell |
8-day EMA: | 0.24 | Sell |
20-day EMA: | 0.3 | Sell |
50-day EMA: | 0.43 | Sell |
200-day EMA: | 8.46 | Sell |
OCUL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.87 | Buy |
20-day SMA: | 8.74 | Buy |
50-day SMA: | 8.42 | Buy |
200-day SMA: | 6.84 | Buy |
8-day EMA: | 8.88 | Buy |
20-day EMA: | 8.71 | Buy |
50-day EMA: | 8.27 | Buy |
200-day EMA: | 6.89 | Buy |
Aptevo Therapeutics Earnings Growth & APVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $32.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $93.60 per share, and an increase next year of $2.02 per share.
Ocular Therapeutix Earnings Growth & OCUL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.17 per share, and an increase next year of $0.11 per share.
Aptevo Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ocular Therapeutix Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |